GWAS identified several genetic variants near the KLF14 gene on chromosome 7 to be associated with a multitude of metabolic pathologies, including insulin resistance, T2D (1–3), and coronary artery disease (CAD) (4). This evidence concerns the gene KLF14 and Insulin resistance.